Introduction d’Intrasense sur NYSE Alternext


Paris, 22 February 2012– NYSE Euronext today announced the listing of Intrasense, a key European publisher of software used in radiology diagnostics, on NYSE Alternext in Paris.

Founded in 2004, with offices in Montpellier, Paris and Shanghai, Intrasense designs, develops and markets Myrian®, an advanced software suite used by experts to analyse medical images in three dimensions. This pioneering system is an invaluable aid to radiologists, surgeons and clinicians, who use it to ensure accurate diagnosis, plan therapy, and track certain pathologies, notably tumors. Intrasense has 44 employees, all bilingual and with a strong international focus, who work in either Research & Development or in marketing.

Intrasense (ticker code: ALINS) was listed through the admission to trading of 2,152,020 existing shares and 571,561 shares (of which 523,941 new shares) issued under a Global Offering[1], including full exercise of the extension clause and the partial exercise of the Over-allotment Option. The Global Offering raised a total of €4.2 million.

The admission and issue price of Intrasense shares was set at €7.40. Market capitalisation stood at around €21 million on the day of listing.

“We are delighted with Intrasense’s successful listing on NYSE Alternext this year’s first on our market with lighter regulatory requirements that is tailor-made  for SMEs. Intrasense is also the third company in the health sector to join us in just a few days” said Marc Lefèvre, Head of European Coverage at NYSE Euronext. “Listing is a milestone that will raise the company’s profile with investors and generate the financing it needs to step up its growth and continue building an efficient international distribution network,” he noted.

Intrasense Chairman Stéphane Chemouny and CEO Patrick Mayette added: “We are very pleased to be the first listing of the year on NYSE Alternext, joining the group of high-growth companies that have turned to the market to finance their development. We would like to take this opportunity to thank our employees, whose dedication adds value to Intrasense technology every day, as well as all the shareholders who have enabled us to list today and gain access to the resources we need to deploy our international strategy. As you now know, Intrasense is a core player in France’s fast-moving medical imaging industry. Our aim is to shape the industry as it advances.”

In six years, €2.6 billion has been raised on NYSE Alternext, half through secondary issues, by companies from countries including Belgium, Canada, China, France, Italy, Luxembourg, the Netherlands, Spain, the UK and the US. Their market capitalization totals €5.9 billion. There are currently 180 companies listed on NYSE Alternext.

[1]The Global Offering was made up of an Open Price Public Offering and a Global Placement with institutional investors in France and other countries.

Press Release Footer

About Euronext 
Euronext is the leading pan-European market infrastructure, connecting European economies to global capital markets, to accelerate innovation and sustainable growth. It operates regulated exchanges in Belgium, France, Ireland, Italy, the Netherlands, Norway and Portugal. With close to 1,930 listed issuers and around €6.8 trillion in market capitalisation as of end March 2023, it has an unmatched blue-chip franchise and a strong diverse domestic and international client base. Euronext operates regulated and transparent equity and derivatives markets, one of Europe’s leading electronic fixed income trading markets and is the largest centre for debt and funds listings in the world. Its total product offering includes Equities, FX, Exchange Traded Funds, Warrants & Certificates, Bonds, Derivatives, Commodities and Indices. The Group provides a multi-asset clearing house through Euronext Clearing, and custody and settlement services through Euronext Securities central securities depositories in Denmark, Italy, Norway and Portugal. Euronext also leverages its expertise in running markets by providing technology and managed services to third parties. In addition to its main regulated market, it also operates a number of junior markets, simplifying access to listing for SMEs.  
For the latest news, follow us on Twitter ( and LinkedIn (

This press release is for information purposes only and is not a recommendation to engage in investment activities. This press release is provided “as is” without representation or warranty of any kind. While all reasonable care has been taken to ensure the accuracy of the content, Euronext does not guarantee its accuracy or completeness. Euronext will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided. No information set out or referred to in this publication may be regarded as creating any right or obligation. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by Euronext’s subsidiaries shall depend solely on the applicable rules of the market operator. All proprietary rights and interest in or connected with this publication shall vest in Euronext.

This press release speaks only as of this date. Euronext refers to Euronext N.V. and its affiliates. Information regarding trademarks and intellectual property rights of Euronext is located at

© 2023, Euronext N.V. - All rights reserved.